New York · Nonprofit
ISRAEL CANCER RESEARCH FUND INC
ISRAEL CANCER RESEARCH FUND INC (New York) receives grants from 270 organizations whose IRS filings report $21,012,024 to it, the largest being PEF ISRAEL ENDOWMENT FUNDS INC ($2,622,974). 142 of them have funded it in more than one year, and 55% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $9.1M
- Funders on record
- 270
- Grants received
- $21M
- Net assets
- $19M
What Israel Cancer Research Fund Inc does
Mission
To support cancer research in israel, for the benefit of israel and all mankind.
As stated on its FY2024 Form 990.
Programs
Provided cancer research funding for israeli scientists. Icrf is the largest non-profit in north america dedicated to supporting cancer research in israel. Over the last nearly 50 years, icrf has provided more than $98 million to support cancer research in israel, funding nearly 3,000 research projects. In 2024, we awarded 58 research grants valued at nearly $3.6m. Typically, 60-80 grants are funded annually, based on an evaluation and prioritization by independent review panels consisting of 40-50 leading cancer scientists from north american biomedical research centers. Icrf grant categories are tailored to support cancer researchers at all of the various stages of their careers, and we are proud to have helped support many of today's most outstanding scientists at the earliest stages in their careers. Icrf seeks to capitalize on the significantly lower costs of conducting cancer research in israel. All awards go directly to the designated researcher without any reduction for overhead.
$3,027,012 spentof which $2,527,154 as grants69% of program spendingSupported the development of the next generation of israeli cancer scientists. Icrf is committed to facilitating the development of future cancer scientists in israel. Towards this end icrf funds three types of grants: postdoctoral fellowship awards, research career development awards, and clinical research career development awards. Fellowships support mds and phds who have just completed their postgraduate training. These awards can be used to support salaries or research costs, while these individuals apprentice in the laboratories of senior investigators. Career development awards are to enhance the research capabilities of young israeli scientists in the formative phase of their careers. Candidates must have demonstrated outstanding potential for contributions to cancer research and must exhibit great potential to become independent investigators research. Supporting these newly launched scientists, enhances their opportunities in israel and allows them to optimize their work without emigrating to other advanced countries.
$879,006 spentof which $725,000 as grants20% of program spendingSupported collaborative cancer research conducted by israeli scientists in association with north american cancer scientists. Cancer science oftentimes requires multi-disciplinary approaches, engagement with highly specialized areas of science, and expensive equipment that is not easily accessed. Collaborations between scientists in israel and north america can address these challenges, foster unexpected synergies, and enhance both intellectual curiosity and innovation. Icrf promotes collaboration by supporting grants that fund promising cancer research projects being conducted on a collaborative basis between investigators in israel and an american or canadian research institution.
$491,031 spentof which $405,000 as grants11% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $4,397,049.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $16M to $19M (+18%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 5% · 2021 3%. Grants only. Government contracts and fees sit inside program revenue.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Bryna Goldberg
Chair
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 56 funders to 99 funders, grant income rose $1.1M → $3.6M.
24 of 270 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 55% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ISRAEL CANCER RESEARCH FUND INC’s funders (the co-funder graph). Top 30 of 270 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ISRAEL CANCER RESEARCH FUND INC has a broad base — no single funder exceeds 12% of grant income, and it takes 7 funders to reach half.
the vertical line marks half of all grant income — 7 funders to its left
60% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ISRAEL CANCER RESEARCH FUND INC.
Largest funder’s share by year: 2017 19% · 2018 25% · 2019 23% · 2020 19% · 2021 18% · 2022 10% · 2023 19% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
41% of ISRAEL CANCER RESEARCH FUND INC's funders are still giving 3 years after their first grant; 53% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
55% of ISRAEL CANCER RESEARCH FUND INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $9.5M that is directly attributable, 79% of it comes from funders outside New York, across 24 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $11M arriving through sponsors registered in 16 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like ISRAEL CANCER RESEARCH FUND INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
70% of spending goes to programs.
Governance
Public support
85%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 24 states
Screen this organization
A dated, signed PDF of the compliance screen for ISRAEL CANCER RESEARCH FUND INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ISRAEL CANCER RESEARCH FUND INC?
- ISRAEL CANCER RESEARCH FUND INC (New York) receives grants from 270 organizations whose IRS filings report $21,012,024 to it, the largest being PEF ISRAEL ENDOWMENT FUNDS INC ($2,622,974). 142 of them have funded it in more than one year, and 55% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does ISRAEL CANCER RESEARCH FUND INC have?
- IRS filings report 270 organizations giving $21,012,024 in grants to ISRAEL CANCER RESEARCH FUND INC, 142 of which have funded it in more than one year.
- Who is the largest funder of ISRAEL CANCER RESEARCH FUND INC?
- PEF ISRAEL ENDOWMENT FUNDS INC is the largest funder on record, with $2,622,974 in grants. The full list of funders is on this page.
- How can an organization like ISRAEL CANCER RESEARCH FUND INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 270 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing